J. Strohschein

Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion.

J. Wischhusen, S. Häusler, A. Hönig, 2014, American journal of translational research.

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity

K. Klotz, J. Wischhusen, S. Häusler, 2011, Cancer Immunology, Immunotherapy.